Literature DB >> 9792910

Post-isolation inducible nitric oxide synthase gene expression due to collagenase buffer perfusion and characterization of the gene regulation in primary cultured murine hepatocytes.

H Wang1, X Gao, S Fukumoto, S Tademoto, K Sato, K Hirai.   

Abstract

The traditional two-step EGTA/collagenase method is widely used in studying nitric oxide (NO) production in hepatocytes. The present study first revealed that hepatocytes isolated by this method spontaneously express an iNOS mRNA. Thereafter, based on this novel finding, we characterized the expression and regulation of the gene in primary cultured hepatocytes. Using Northern blot analysis, the iNOS mRNA was observed 4 h after isolation, reached peak at 8 h, and declined to an undetectable level after 24 h. iNOS gene expression was shown to be serum-independent and not due to lipopolysaccharide contamination. Time-course analysis of the effects of actinomycin D demonstrated that the increase in iNOS transcripts is the result of an accompanying great increase in iNOS gene transcription and lower iNOS mRNA stability; also blockage by cycloheximide suggests that it is dependent on de novo protein synthesis. Inhibition by pyrrolidine dithiocarbamate, a NF-kappaB/c-rel inhibitor, further implies the involvement of NF-kappaB/c-rel. To clarify reason(s) for the induction, hepatocytes were isolated with the collagenase buffer perfusion step omitted. As a consequence, iNOS mRNA was undetectable in the hepatocytes. These findings show that the traditional hepatocyte-isolation culture does indeed transiently express a serum-independent but de novo protein synthesis-dependent iNOS mRNA due to collagenase (type IV) buffer perfusion.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792910     DOI: 10.1093/oxfordjournals.jbchem.a022204

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  7 in total

1.  Microengineered cell and tissue systems for drug screening and toxicology applications: Evolution of in-vitro liver technologies.

Authors:  O B Usta; W J McCarty; S Bale; M Hegde; R Jindal; A Bhushan; I Golberg; M L Yarmush
Journal:  Technology (Singap World Sci)       Date:  2015-03

2.  The threefold protrusions of adeno-associated virus type 8 are involved in cell surface targeting as well as postattachment processing.

Authors:  Christina Raupp; Matthias Naumer; Oliver J Müller; Brittney L Gurda; Mavis Agbandje-McKenna; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2012-06-20       Impact factor: 5.103

3.  In vitro models for liver toxicity testing.

Authors:  Valerie Y Soldatow; Edward L Lecluyse; Linda G Griffith; Ivan Rusyn
Journal:  Toxicol Res (Camb)       Date:  2012-11-23       Impact factor: 3.524

4.  Suppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome.

Authors:  Kahori Shimizu; Fuminori Sakurai; Kyoko Tomita; Yasuhito Nagamoto; Shin-Ichiro Nakamura; Kazufumi Katayama; Masashi Tachibana; Kenji Kawabata; Hiroyuki Mizuguchi
Journal:  Mol Ther Methods Clin Dev       Date:  2014-09-03       Impact factor: 6.698

5.  Scoparone affects lipid metabolism in primary hepatocytes using lipidomics.

Authors:  Aihua Zhang; Shi Qiu; Hui Sun; Tianlei Zhang; Yu Guan; Ying Han; Guangli Yan; Xijun Wang
Journal:  Sci Rep       Date:  2016-06-16       Impact factor: 4.379

6.  Adenovirus vector-mediated macrophage erythroblast attacher (MAEA) overexpression in primary mouse hepatocytes attenuates hepatic gluconeogenesis.

Authors:  Kahori Shimizu; Minako Okamoto; Tomoyuki Terada; Fuminori Sakurai; Hiroyuki Mizuguchi; Koji Tomita; Toru Nishinaka
Journal:  Biochem Biophys Rep       Date:  2017-04-20

7.  Biphasic modulation of NOS expression, protein and nitrite products by hydroxocobalamin underlies its protective effect in endotoxemic shock: downstream regulation of COX-2, IL-1β, TNF-α, IL-6, and HMGB1 expression.

Authors:  André L F Sampaio; Jesmond Dalli; Vincenzo Brancaleone; Fulvio D'Acquisto; Mauro Perretti; Carmen Wheatley
Journal:  Mediators Inflamm       Date:  2013-05-28       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.